Pharmacokinetics of celecoxib after oral administration in dogs and humans: Effect of food and site of absorption

Journal of Pharmacology and Experimental Therapeutics

Volumn 297, Issue 2, 2001, Pages 638-645

  Paulson, Susan K ^a,b   Vaughn, Margaret B ^a   Jessen, Susan M ^a   Lawal, Yvette ^a   Gresk, Christopher J ^a   Yan, Bo ^a   Maziasz, Timothy J ^a   Cook, Chyung S ^a   Karim, Aziz ^a  

^a Pharmacia ^*  (United States)

^b Pharmacia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; COLON; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DOSAGE FORM; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STRUCTURE; DUODENUM; FEMALE; FOOD DRUG INTERACTION; GASTROINTESTINAL ABSORPTION; HUMAN; HUMAN EXPERIMENT; JEJUNUM; LIPID DIET; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0035040782     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Physiochemical and physiological mechanisms for the effects of food on drug absorption: The role of lipids and pH
2. Physiological parameters in laboratory animals and humans
3. Comparison of canine and human gastrointestinal physiology
4. Drug, meal and formulation interactions influencing drug absorption after oral administration: Clinical implications
5. Specific COX-2 inhibitors: From bend to bedside
6. Importance of food effect studies in early drug development
7. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue
8. The effect of food and bile acid administration on the relative bioavailability of cyclosporin
9. Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and nonulcerogenic
10. A chronic access port model for direct delivery of drugs into the intestine of conscious dogs
11. Effect of size and density on canine gastric emptying of nondigestible solids
12. The discovery and function of COX-2
13. Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib
14. 14C] celecoxib in healthy male volunteers
15. Pharmacokinetics, tissue distribution, metabolism and excretion of celecoxib in rats
16. Comparison of celecoxib metabolism and excretion in mouse, rabbit, dog cynomolgus monkey and rhesus monkey
17. Regulation of fibroblast cyclooxygenase synthesis by interleukin-1
18. Gastrointestinal toxicity with celecoxib versus nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study, a randomized controlled trial
19. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial
20. Effects of food on clinical pharmacokinetics
21. Aspirin selectively inhibits prostaglandin production in human platelets
22. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
23. Effects of food on drug absorption
24. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing